title: Do calcium channel blockers appear to have a protective effect on the development of prostate cancer clinically?
authors.affiliation: Department of Urology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, PR China.
authors.forename: Peng
authors.initials: P
authors.lastname: Zhang
authors.affiliation: Department of Urology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, PR China.
authors.forename: Wan-Li
authors.initials: WL
authors.lastname: Hu
authors.affiliation: Department of Urology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, PR China.
authors.forename: Xing-Huan
authors.initials: XH
authors.lastname: Wang
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D020746:Calcium Channels, L-Type / Q000378:metabolism; D045744:Cell Line, Tumor; D059865:Endoplasmic Reticulum Stress / Q000187:drug effects; D006801:Humans; D008297:Male; D011467:Prostate / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D020011:Protective Agents / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: C472073:CACNA1D protein, human; D002121:Calcium Channel Blockers; D020746:Calcium Channels, L-Type; D020011:Protective Agents; D002118:Calcium